SBS shares fell roughly 17.8% over the last 30 days, sliding from about $5.61 to $4.61. The sharpest leg lower followed second-quarter 2026 results, which missed revenue and earnings consensus.

Reported net income came in at R$1.46 billion for Q2 2026, down 31.4% year over year and just below the R$1.53 billion consensus compiled by LSEG. Total net revenue rose 13.9% to R$10.21 billion, while adjusted net revenue grew 6.7% to R$6.01 billion.

CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.

The target price for CDZIP is $18.29, which represents an 8% increase from the breakout price of $17.17. This price target is based on the height of the triangle pattern, which is measured from the highest point of the triangle to the lowest point, and then projected upwards from the breakout point.

Water-treatment company AquaVenture’s stock  was downgraded by two investment banks, after the announcement of an acquisition. On Monday, it was revealed that Culligan International, backed by  private-equity firm Advent International, would acquire AquaVenture for $27.10 a share cash, or about $1.1 billion, including AquaVenture's net debt.The deal, already approved by AquaVenture's board , is expected to close in early April. Raymond James analyst Pavel Molchanov lowered his rating  on the stock to market perform from outperform.  Molchanov  mentioned in a note to investors that Culligan is "a very logical buyer” and  it is unlikely that any other firms will engage in a bidding war. The analyst indicated that he was expecting continued strong M&A activity in the water industry in 2020.